Clinical Trial Update: Study of Toripalimab for Limited-Stage Small Cell Lung Cancer Following Concurrent Chemoradiotherapy [Phase 2]

View source ↗

Summary

A Phase 2 trial of toripalimab for limited-stage small cell lung cancer after chemoradiotherapy has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Toripalimab (Toripalimab)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Small Cell Lung Cancer Limited Stage | Phase 2 | Status: TERMINATED